Synopsis
Synopsis
0
USDMF
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 4-(4-bromophenyl)-1-(4-(4-fluorophenyl)-4-oxobutyl)-4-piperidinyl Decanoate
2. Impromen Decanoas
1. 75067-66-2
2. 4-(4-bromophenyl)-1-(4-(4-fluorophenyl)-4-oxobutyl)piperidin-4-yl Decanoate
3. 73lg72m4lv
4. R-46541
5. Decanoic Acid,4-(4-bromophenyl)-1-[4-(4-fluorophenyl)-4-oxobutyl]-4-piperidinyl Ester
6. Bromperidol Decanoate (usan)
7. R-46,541
8. Bromperidol Decanoate [usan]
9. Decanoic Acid, 4-(4-bromophenyl)-1-(4-(4-fluorophenyl)-4-oxobutyl)-4-piperidinyl Ester
10. Unii-73lg72m4lv
11. Bromperidoldecanoat
12. Bromperidol Decanoate [usan:ban]
13. Einecs 278-065-1
14. [4-(4-bromophenyl)-1-[4-(4-fluorophenyl)-4-oxobutyl]piperidin-4-yl] Decanoate
15. Bromoperidol Decanoate
16. R 46541
17. Schembl121019
18. Chembl2106135
19. Dtxsid30226039
20. Bromperidol Decanoate [mart.]
21. 4-(4-bromophenyl)-1-(4-(4-fluorophenyl)-4-oxobutyl)-4-piperidinyl Decanoate
22. Bromperidol Decanoate [usp-rs]
23. Bromperidol Decanoate [who-dd]
24. 4-(4-(p-bromophenyl)-4-hydroxypiperidinol)-4'-fluorobutyrophenone Decanoate (ester)
25. Bromperidol Decanoate [ep Impurity]
26. Bromperidol Decanoate [ep Monograph]
27. D02626
28. R 46,541
29. Q27266190
30. 4-(4-(p-bromophenyl)-4-hydroxypiperidinol)-4'-fluorobutyrophenone Decanoate
Molecular Weight | 574.6 g/mol |
---|---|
Molecular Formula | C31H41BrFNO3 |
XLogP3 | 7.9 |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 5 |
Rotatable Bond Count | 16 |
Exact Mass | 573.22538 g/mol |
Monoisotopic Mass | 573.22538 g/mol |
Topological Polar Surface Area | 46.6 Ų |
Heavy Atom Count | 37 |
Formal Charge | 0 |
Complexity | 665 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Antipsychotic Agents
Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus. (See all compounds classified as Antipsychotic Agents.)
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?